Research Article
High Expression of Somatostatin Receptors 2A, 3, and 5 in Corticotroph Pituitary Adenoma
Table 2
Patient cohort characteristics.
| | (%) |
| Corticotroph | 88 (100) | Gender | Male | 18 (20) | Female | 70 (80) | Age at diagnosis | Median (years) | 49 | Range (years) | 16–79 | Primary | 68 (77) | Recurrence | 20 (23) |
| PIT-1 positive | 55 (100) | Gender | Male | 27 (49) | Female | 28 (51) | Age at diagnosis | | Median (years) | 50 | Range (years) | 17–75 | Primary | 47 (85) | Recurrence | 8 (15) |
| Gonadotroph | 22 (100) | Gender | Male | 11 (50) | Female | 11 (50) | Age at diagnosis | Median (years) | 54 | Range (years) | 37–79 | Primary | 15 (68) | Recurrence | 7 (32) |
| Nonfunctioning | 82 (100) | Gender | Male | 45 (55) | Female | 37 (45) | Age at diagnosis | Median (years) | 49 | Range (years) | 29-81 | Primary | 45 (55) | Recurrence | 37 (45) |
| Nonadenomatous pituitary biopsy | 30 (100) | Gender | Male | 8 (27) | Female | 22 (73) | Age at diagnosis | Median (years) | 44 | Range (years) | 19-76 | Primary | 20 (33) | Recurrence | 10 (67) |
|
|